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We examined the hypothesis that stromal fibroblasts modulate the ability of endothelial
cells (EC) to recruit lymphocytes in a site-specific manner. PBL were perfused over HUVEC
that had been cultured with fibroblasts isolated from the inflamed synovium or the skin of
patients with rheumatoid arthritis or osteoarthritis, or from normal synovium, with or
without exposure to the inflammatory cytokines TNF-a+IFN-c. Fibroblasts from inflamed
synovium, but no others, caused unstimulated HUVEC to bind flowing lymphocytes. This
adhesion was supported by a4b1-VCAM-1 interaction and stabilised by activation of PBL
through CXCR4–CXCL12. Antibody neutralisation of IL-6 during co-culture effectively
abolished the ability of EC to bind lymphocytes. Cytokine-stimulated EC supported high
levels of lymphocyte adhesion, through the presentation of VCAM-1, E-selectin and
chemokine(s) acting through CXCR3. Interestingly, co-culture with dermal fibroblasts
caused a marked reduction in cytokine-induced adhesion, while synovial fibroblasts had
variable effects depending on their source. In the dermal co-cultures, neutralisation of IL-6
or TGF-b caused partial recovery of cytokine-induced lymphocyte adhesion; this was
complete when both were neutralised. Exogenous IL-6 was also found to inhibit response
to TNF-a+IFN-c. Normal stromal fibroblasts appear to regulate the cytokine-sensitivity of
vascular endothelium, while fibroblasts associated with chronic inflammation bypass this
and develop a directly inflammatory phenotype. Actions of IL-6 might be pro-inflamma-
tory or anti-inflammatory, depending on the local milieu.
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Introduction
Vascular endothelial cells (EC) regulate leukocyte recruitment
during inflammation. In response to cytokines such as TNF-a or
IFN-g, EC up-regulate expression of selectins and members of the
immunoglobulin superfamily and generate and present chemo-
kines, thus promoting leukocyte adhesion and migration [1, 2].
The local physiochemical microenvironment, including haemo-
dynamic forces and sub-endothelial stroma, can influence these
endothelial responses, thus modulating leukocyte recruitment
[3, 4]. Of particular interest here is the ability of stromal cells to
induce or modify the pro-inflammatory responses of EC.
In vivo, EC are rarely found in isolation but are usually adja-
cent to pericytes and other stromal cells including fibroblasts and
smooth muscle cells (SMC). Recent studies by ourselves and
others show that stromal cells can strongly influence endothelial
recruitment of several types of leukocyte [5–9]. Culturing human
HUVEC and bronchial epithelial cells together on opposite sides
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of a filter promoted neutrophil transmigration towards IL-8 [6],
while dermal fibroblasts from scleroderma patients promoted
transmigration of a T-cell line through an immortalised HUVEC
line [5]. Using flow-based models, we found that co-culturing
HUVEC with secretory SMC augmented the capture of neutro-
phils, monocytes and lymphocytes induced by TNF-a [7]. In
addition, crosstalk between hepatic sinusoidal EC and hepato-
cytes induced lymphocyte adhesion in the absence of exogenous
cytokines and amplified recruitment in response to lymphotoxin
[8]. Most recently, we demonstrated that HUVEC cultured with
fibroblasts from the synovium of patients with rheumatoid
arthritis (RA) supported the capture of flowing neutrophils in the
absence of exogenous cytokines, a response not seen with dermal
fibroblasts [9].
There is growing evidence that fibroblasts are a hetero-
geneous population that demonstrate topographic and positional
memory, even within a single tissue [10–12]. This led us to
propose that there might be a ‘stromal post-code’ for fibroblasts
from different anatomical sites, which reflected their potential to
differentially influence leukocyte recruitment and subsequent
fate in inflammation [4]. Here, we set out to evaluate this concept
by testing whether fibroblasts could directly induce lymphocyte
recruitment by EC, or modulate the responses of EC to cytokines,
depending on the origin of the fibroblasts. Our studies indicated
that ‘normal’ fibroblasts from non-inflamed tissue could modulate
the ability of cytokine-treated HUVEC to recruit flowing
lymphocytes, while fibroblasts associated with chronic inflam-
mation (from the arthritic synovium) could directly induce
lymphocyte adhesion. Interestingly, we detected differential
effects of IL-6 generated in these co-cultures on lymphocyte
recruitment, depending on the co-culture and cytokine milieu.
Results
Adhesion of flowing lymphocytes to endothelial-
fibroblast co-cultures
EC and fibroblasts were co-cultured on opposite sides of transwell
filters, and the filters were cut out and incorporated into a
parallel plate flow chamber allowing the direct visualisation of
lymphocyte adhesion to EC using phase contrast microscopy.
Initially we examined whether fibroblasts could induce endothe-
lial responses in the absence of exogenous cytokines. Unstimu-
lated EC mono-cultures supported only low levels of lymphocyte
adhesion from flow (Fig. 1A). Interestingly, synovial fibroblasts
from inflamed joints of patients with RA or osteoarthritis (OA)
induced lymphocyte adhesion to co-cultured EC in the absence of
exogenous cytokines (Fig. 1A). The great majority of these
adherent lymphocytes (90%) were stationary, firmly adherent
cells, and a small sub-population were rolling (2.270.8 or
12.879.3% of adherent cells were rolling on EC co-cultured with
RA or OA synovial fibroblasts, respectively; mean7SEM for
n5 13 or 3 experiments). A sub-population of the adherent cells
had migrated through the endothelial monolayer by 10min after
washout (7.672.0 or 18.579.3% of adherent cells migrated
through EC co-cultured with RA or OA synovial fibroblasts
respectively; mean7SEM for n5 13 or 3 experiments). In
contrast, lymphocyte adhesion to EC cultured with dermal
fibroblasts from the same donors was not significantly above
that observed on mono-cultures, and synovial fibroblasts from a
patient undergoing knee surgery due to mechanical injury
(trauma) also failed to up-regulate adhesion to EC (Fig. 1A).
Next, we examined whether the crosstalk between fibroblasts
and EC during co-culture could alter the endothelial responses to
cytokines. On the basis of previous work by ourselves and others
([13–15]; see also Materials and methods), we initially studied
adhesion induced by 100U/mL of TNF-a alone, or combined with
10 ng/mL of IFN-g. Lymphocytes adhered efficiently to EC
stimulated with either treatment (Fig. 1B). While a significant
proportion of adherent cells rolled on the surface (20%), most
were stationary and firmly adherent, and a significant proportion
(30%) went on to migrate through the endothelial monolayer
(Fig. 1C). In agreement with previous studies [13, 15], the
cytokine combination tended to support greater adhesion and
more firm adhesion, and so was used in further co-culture
experiments. In this model, the ‘non-stimulatory’ fibroblasts from
the skin of patients with RA or OA, or from normal (trauma)
synovium, all markedly reduced the number of lymphocytes
adhering to cytokine-stimulated EC compared with stimulated
mono-cultures (Fig. 1C). Synovial fibroblasts from RA patients
tended to increase the endothelial responses (although not
significantly), but synovial fibroblasts from OA patients inhibited
lymphocyte adhesion in the cytokine-treated co-cultures,
although to a slightly lesser extent than the dermal fibroblasts
(Fig. 1C). The lymphocytes that did bind to the cytokine-treated
EC co-cultured with dermal fibroblasts were nevertheless firmly
adherent, with o10% rolling.
The above data suggest that although fibroblasts from
chronically inflamed synovium induce inflammatory responses,
healthy ‘resting’ fibroblasts (dermal or synovial) limit the endo-
thelial response to cytokines. In all further experiments we
compared the genetically matched dermal and synovial fibro-
blasts isolated from RA patients.
Effect of blocking adhesion or chemokine receptors on
lymphocyte adhesion
We examined the mechanisms supporting adhesion of lympho-
cytes to unstimulated EC cultured with synovial fibroblasts.
Lymphocytes were treated with function-blocking antibodies
against a4-integrin or CXCR3 (which binds IFN-g-inducible
chemokines), or with an antagonist of CXCR4 (receptor for
CXCL12/stromal derived factor-1a (SDF-1a)) before perfusion.
Adhesion was essentially abolished when a4-integrins were
blocked and greatly reduced when CXCR4 was inhibited, but
blockade of CXCR3 was ineffective (Fig. 2A).
Subsequently, we analysed lymphocyte adhesion to
cytokine-treated endothelial mono-cultures after treatment with
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function-blocking antibodies against key adhesion and chemo-
kine receptors. Pre-treatment of EC with antibody against
domain 1 of VCAM-1 caused slight but non-significant reduction,
antibody against domain 4 had a greater and significant effect,
while blockade of both domains reduced adhesion by 88%
(Fig. 2B). Antibody against E-selectin also tended to reduce
adhesion. Although this effect was not significant, when
treatment was combined with antibody against domain 1 of
VCAM-1, there was a significant reduction in adhesion.
When lymphocytes were treated with antibody against b2-integ-
rin there was no reduction in adhesion, but blockade of
a4-integrin reduced adhesion markedly, to a level close to that
when both domains of VCAM-1 were blocked (Fig. 2B). Thus, the
interaction between a4-integrin and VCAM-1 was the main
mechanism for binding (capture and firm adhesion) of
flowing lymphocytes, although E-selectin might also have
contributed in the capture phase. In contrast to the studies with
unstimulated co-cultures, anti-CXCR3 antibody treatment caused
a significant (80%) reduction in lymphocyte adhesion to
cytokine-stimulated EC, while inhibiting CXCR4 had no signifi-
cant effect (Fig. 2B).
Collectively, these data suggest that initial lymphocyte
binding and firm adhesion were supported by interaction
of a4b1-integrin with VCAM-1 in both models. However,
lymphocyte adhesion was stabilised by activation through
CXCL12 in the unstimulated system, while CXCR3 ligands
were responsible for stabilisation in the cytokine-treated
model.
Effect of co-culture onmRNA and surface expression of
E-selectin and VCAM-1 by EC
To further investigate the mechanisms by which fibroblasts
modulated lymphocyte adhesion to endothelium, we used
quantitative real-time PCR (qPCR) and flow cytometry to
examine the effect of fibroblasts on the mRNA and surface-
protein expression of E-selectin and VCAM-1 by co-cultured EC.
Low levels of mRNA for E-selectin and VCAM-1were detected in
unstimulated EC, but expression was dramatically up-regulated
following cytokine treatment (Fig. 3). Co-culture caused a slight
up-regulation of E-selectin and VCAM-1 mRNA expression by
Figure 1. Lymphocyte adhesion to EC cultured alone or with fibroblasts, with or without cytokine treatment. (A) Adhesion to unstimulated EC
cultured alone (None) or co-cultured with dermal or synovial fibroblasts from patients with RA or OA, or with synovial fibroblasts from a patient
suffering from mechanical trauma. (B) Adhesion to endothelial mono-cultures unstimulated or stimulated with TNF-a or TNF-a+IFN-g. (C)
Behaviour of lymphocytes adherent to endothelial mono-cultures stimulated TNF-a or TNF-a+IFN-g (analysed 10 min after washout). (D)
Endothelial mono- or co-cultures stimulated with TNF-a+IFN-g. Data are mean7SEM from 3 to 11 independent experiments, using at least 3
different donors for each cell type, except for ‘trauma’ where fibroblasts from a single donor were tested on 2 occasions. In all experiments, co-
cultures were compared with mono-cultures (None), and data are expressed as a percentage of that observed in the paired control (None), which
itself was normalised to 100%. po0.05, po0.01 for comparison to ‘None’ by paired t-test.
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unstimulated EC, but this effect was similar for each type of
fibroblast from RA donors, and expression remained far below
levels for cytokine-treated cells (Fig. 3A and B). Co-culture with
either type of fibroblast had no consistent effect on mRNA
expression of E-selectin or VCAM-1 by cytokine-stimulated EC
(Fig. 3C and D).
Judged by flow cytometry, surface levels of E-selectin and
VCAM-1 were barely above background for unstimulated EC co-
cultured with either fibroblast type (data not shown). Cytokine-
treated EC showed strong expression of these receptors, and there
was a tendency towards a reduction in E-selectin and VCAM-1
surface expression on co-cultures compared with EC cultured
alone (Fig. 4). However, these effects were not statistically
significant and similar trends were observed for each type of
fibroblast from RA donors.
Overall, changes in mRNA and surface expression of the
identified endothelial capture receptors did not show clear
differences between effects of co-culture with dermal or synovial
fibroblasts, or correlate with functional changes.
Effect of co-culture on mRNA expression of
chemokines by EC
Data presented above demonstrated a major role for CXCL12
(SDF-1) in the increased adhesion of lymphocytes to unstimu-
lated EC co-cultured with synovial fibroblasts. Previously we
showed that synovial fibroblasts expressed significantly more
CXCL12 mRNA than dermal fibroblasts [16]. Here, we evaluated
CXCL12 mRNA levels in EC using qPCR. Unstimulated and
cytokine-stimulated EC expressed very low levels of mRNA for
CXCL12 (relative expression units (REU) o0.001 relative to
b-actin in each case). Although co-culture with either type of
fibroblast from RA donors significantly increased these levels in
the absence of cytokines (REU50.00670.001 or 0.00370.001
for dermal or synovial co-cultures, respectively; mean7SEM
n5 3, po0.05 compared with EC alone by Dunnett’s test), the
levels remained low and were not significantly different between
the fibroblasts. In the presence of cytokines, the levels of CXCL12
mRNA were not significantly affected by culture with fibroblasts
(data not shown).
CXCR3 ligands were important in lymphocyte adhesion to
cytokine-treated EC. Thus we analysed the effect of co-culture on
the expression of the ligands for CXCR3 by EC using RT-PCR.
High levels of mRNA for the CXCR3 ligands, CXCL9 (Mig),
CXCL10 (IP-10) and CXCL11 (I-TAC) were detectable in EC
treated with TNF-a+IFN-g, but these levels were not modified by
co-culture with either fibroblast type (data not shown).
Collectively, the above data showed no effects of co-culture on
the expression of chemokines by EC that correlated with the
recruitment patterns we observed with either unstimulated or
cytokine-treated cells.
Requirement for direct contact between EC and
fibroblasts
Next, we analysed whether direct contact between EC and
fibroblasts from RA patients was required to generate the
different lymphocyte adhesion patterns. Fibroblasts were
cultured in the bottom of the plate, while EC were grown inside
the filters, thereby ensuring no direct contact. Unstimulated
EC that had been cultured in the presence of synovial fibroblasts
bound lymphocytes efficiently from flow (103732 cells/
mm2/106 perfused versus 3079 cells/mm2/106 perfused for EC
mono-cultures; mean7SEM; n53). Dermal fibroblasts
from RA patients again inhibited the response to TNF-a+IFN-g
treatment, with adherent lymphocyte being reduced by 52710%
(mean7SEM; n5 3) compared with cytokine-treated endothelial
mono-cultures (po0.05 by paired t-test). The presence of
synovial fibroblasts without contact did not significantly alter
adhesion of lymphocytes to the cytokine-treated EC (data not
Figure 2. Effects of blocking adhesion receptors and chemokines on
lymphocyte adhesion to (A) unstimulated endothelial-RA synovial
fibroblast co-cultures or (B) endothelial mono-cultures treated with
TNF-a+IFN-g. HUVEC were treated with antibodies against E-selectin
(ENA-2) and/or VCAM-1 (4B2 and GH12, against domains 1 and 4,
respectively) for the last 30 min of the 24 h cytokine treatment.
Lymphocytes were incubated for 15 min with antibodies against a4-
integrin (Max68P), CXCR3 (1C6), b2-integrins (R6.5E) or with the CXCR4
inhibitor, AMD3100, before perfusion. Alternatively, Lymphocyte adhe-
sion was expressed as a percentage of control (untreated), which itself
was normalised to 100%. Data are mean7SEM from at least three
independent experiments. Not all antibodies were used in all experi-
ments, but treated cells were always compared with paired untreated
controls. po0.01 for comparison to untreated by paired t-test.
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shown). Collectively, these findings suggest that both the
intrinsic pro-inflammatory effects of co-culture with synovial
fibroblasts and the ability of dermal fibroblasts to suppress
inflammatory responses arose from the release of soluble
mediators. The magnitude of the responses induced without
contact (noted above) tended to be less than that shown in
Figure 1 where cells were only separated by a porous filter. Thus,
close juxtaposition of fibroblasts with EC may potentiate the
activity of such mediators, but direct contact did not appear to be
essential.
Roles of IL-6 or TGF-b in modulation of lymphocyte
adhesion
We previously identified IL-6 as a soluble promoter of the
adhesion of neutrophils in a similar unstimulated co-culture
model [9]. Here, significantly more IL-6 was produced in
endothelial co-cultures with synovial fibroblasts than in
co-cultures with dermal fibroblasts from the same RA donors
in the absence of exogenous cytokines (2.9270.52 ng/mL
compared with 0.6470.14 ng/mL, respectively; mean7SEM
n5 9, po0.01 by paired t-test). Neutralising antibodies
against IL-6 or TGF-b were added to the co-cultures for 24 h
before the assay. Neutralisation of IL-6 caused a significant
reduction in lymphocyte adhesion to EC cultured with synovial
fibroblasts, while neutralisation of TGF-b had no significant effect
(Fig. 5A).
Next we investigated the agent(s) suppressing responses to
cytokines in co-cultures of RA dermal fibroblasts with EC. In this
case, neutralisation of IL-6 or TGF-b in co-cultures caused a
partial recovery of lymphocyte adhesion towards the level in
cytokine-treated mono-cultures, and recovery was complete
when both IL-6 and TGF-b were neutralised (Fig. 5B). Neutra-
lising IL-6 or TGF-b had no effect on lymphocyte adhesion to
cytokine-stimulated EC cultured with synovial fibroblasts (data
not shown).
Since soluble IL-6 appeared to play a role in inducing
adhesion in unstimulated co-cultures, and in inhibiting adhesion
in cytokine-treated co-cultures, we tested the effects of adding
IL-6 to EC. When exogenous IL-6 (10 ng/mL) was added to
otherwise unstimulated endothelial mono-cultures, it failed
to induce EC to support lymphocyte adhesion (Fig. 5C).
On the other hand, treating EC for 24 h with IL-6 (at 1
or 10ng/nL; concentrations similar to those detected in
either dermal or synovial co-cultures) prior to the addition of
TNF-a+IFN-g dramatically reduced lymphocyte adhesion in
response to the cytokines (Fig. 5C).
In general, IL-6 signals in cells through ligation of a
compound receptor comprised Gp130 (CD130) and IL-6Ra
(IL-6 receptor alpha; CD126) ([17, 18], for reviews). Gp130 is a
component of several dimeric receptors for different cytokines
Figure 3. Effect of RA co-culture on the mRNA expression of E-selectin or VCAM-1 by EC. Endothelial mRNA was isolated from (A and B)
unstimulated or (C and D) cytokine (TNF-a+IFN-g) treated co-cultures and gene expression of (A and C) E-selectin or (B and D) VCAM-1 was
assessed by qPCR. In (A) and (B), ANOVA shows a significant effect of co-culture on E-selectin expression (po0.05) and borderline significance of co-
culture on VCAM-1 expression (p5 0.08). Values were expressed as REU compared with b-actin. Data are mean7SEM from three independent
experiments, using three different donors for each cell type. po0.05 compared with None by Dunnett’s test.
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and is expressed in many cells including EC. However, IL6Ra has
more restricted expression and others have indicated that
IL-6 has no detectable effect on the responses of HUVEC
unless soluble sIL-6Ra is present [19]. We checked the
expression of Gp130 and IL-6Ra mRNA in EC using qPCR,
with or without co-culture with fibroblasts. The expression of
Gp130 was about 100 times higher than IL-6Ra in EC (REU
relative to 18 S was 1.670.2 104 versus. 1.47106,
respectively; mean7SEM from six measurements; two each
from EC cultured alone, with dermal or with synovial fibroblasts,
with no consistent differences between mono-cultures and co-
cultures). Nevertheless, IL-6Ra was always detected by qPCR
before cycle 35 in the six measurements, suggesting a low level of
mRNA was present. We thus tested whether IL-6Ra was present
on EC using immunofluorescence and flow cytometry. In two
experiments, surface IL-6Ra was not detectable for mono-cultures
or co-cultures (MFI relative to IgG1 control5 0.9270.05;
mean7SEM from six measurements; two each from EC cultured
alone, with dermal or with synovial fibroblasts,) and in two
experiments MFI relative to IgG1 control was just detectable
for mono-cultures or co-cultures (MFI relative to IgG1
control51.4270.07). Thus, IL-6Ra mRNA and surface protein
were near the limits of detectability in the EC in mono-culture or
co-culture.
Microarray analysis of gene transcription by EC during
co-culture
The functional responses induced or modified by co-culture were
not clearly linked to changes in the expression of single genes
Figure 4. Effect of RA co-culture on the surface expression of
E-selectin or VCAM-1 by EC. EC from cytokine treated co-cultures were
stained with antibodies against (A) E-selectin or (B) VCAM-1 and
surface expression was assessed by flow cytometry (expressed as MFI).
Data are mean7SEM from three independent experiments, using three
different donors for each cell type.
Figure 5. Effect of neutralising IL-6 or TGF-b, or of adding IL-6 on
lymphocyte adhesion. (A) Neutralisation in unstimulated endothelial-
RA synovial fibroblasts co-cultures; (B) neutralisation in cytokine-
stimulated endothelial-RA dermal fibroblasts co-cultures; (C) addition
of IL-6 to unstimulated or cytokine-stimulated EC mono-cultures. Data
are mean7SEM from at least three experiments, using at least three
different donors for each cell type. In all cases, ANOVA showed a
significant effect of treatment on lymphocyte adhesion (po0.01).
po0.05 and po0.01 by Bonferroni test compared with co-cultures
without neutralisation in (A) and (B), or to cytokine-treated mono-
culture without IL-6 in (C).
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(either for adhesion molecules, chemokines or IL-6 receptors).
Nevertheless, IL-6 was implicated in distinct and diverse effects
for the different co-cultures, suggesting that the underlying state
of the EC may have been altered under the different culture
conditions. To investigate this possibility, we used DNA micro-
array technology to examine changes in the transcriptional
profiles of EC cultured alone or with the different fibroblasts
from RA donors. The microarray analysed 850 immune-response
genes (associated with adhesion and chemokine receptors,
cytokines, apoptosis, cell cycle and intracellular signalling path-
ways). Our aim was to test whether the cells had taken on
separate genomic ‘inflammatory’ phenotypes, rather than to
identify specific genes that might be linked to altered function.
Indeed, at a 0% false-positive level, ‘statistical analysis of
microarrays’ (SAM) indicated that there were 18 genes
that varied significantly between the three culture-conditions
(Fig. 6A). Subsequent hierarchical clustering analysis (HCA)
based on these genes showed distinct segmentation between
the transcriptional profiles of the endothelial mono- and co-
cultures (Fig. 6B). Interestingly, EC co-cultured with synovial
fibroblasts displayed a transcriptional phenotype further removed
from EC cultured alone than EC co-cultured with dermal
fibroblasts (Fig. 6). This trend was borne out by individual
comparisons of culture conditions, where 79 genes showed
significant differences between EC cultured alone or with
synovial fibroblasts, and only two genes were significantly
different between EC cultured alone or with dermal fibroblast
(data not shown). Thus, microarray analysis indicated that EC
cultured with RA synovial fibroblasts had developed a separate
phenotype from EC cultured with dermal fibroblast and from
those in mono-culture.
Discussion
Fibroblasts, once believed to be relatively inert cellular compo-
nents of the tissue, are now believed to play an important role in
tissue homeostasis, in particular, in regulating leukocyte recruit-
ment in inflammation [4, 10]. Here we have demonstrated for the
first time that fibroblasts can stimulate recruitment of lympho-
cytes, or limit this response in EC, depending on the tissue from
which the fibroblasts were obtained. When fibroblasts from the
synovium of patients with RA or OA were cultured with EC,
adhesion of flowing lymphocytes was induced even in the
absence of added cytokines. In contrast, dermal fibroblasts from
the same donors, and fibroblasts from non-inflamed synovium,
had little effect on adhesion to otherwise unstimulated EC, but
actually reduced the number of lymphocytes binding in the
presence of cytokines TNF-a+IFN-g. In the cytokine-stimulated
model, the fibroblasts from inflamed synovium were less
consistent in their effects, with those from RA patients tending
to be stimulatory, but those from OA patients being inhibitory.
The responses induced by synovial or dermal fibroblasts from RA
patients appeared to be largely caused by soluble mediators.
These may have been made more effective by close juxtaposition
of cells, but direct contact between cells was not essential.
Interestingly, IL-6 had opposing effects depending on the milieu:
it was essential for the stimulatory effects of synovial fibroblasts
in the absence of added cytokines, but in the presence of TNF-
a+IFN-g, IL-6 along with TGF-bmediated the inhibitory effects of
dermal fibroblasts.
Adhesion of lymphocytes to EC cultured with RA synovial
fibroblasts was essentially abolished by blockage of a4-integrin and
greatly reduced by inhibition of CXCR4, the receptor for CXCL12
(SDF-1). This is consistent with previous studies showing that
interaction between a4b1-integrin and VCAM-1 can support
capture of flowing lymphocytes by EC and that activation of this
integrin is required to stabilise adhesion [20, 21]. Although
CXCL12 has been shown to fulfil such an integrin-activating and
adhesion stabilising role when added exogenously [22], this is the
first report of activity of endogenous, cell-generated CXCL12. We
previously found that CXCL12 was constitutively expressed and
secreted by rheumatoid synovial fibroblasts [16]. Since CXCL12
mRNA was barely detectable in EC here, and there are no reports
of endogenous CXCL12 activity in HUVEC, it is highly likely
that CXCL12 was transferred from the synovial fibroblasts and
presented by the EC during co-culture. We found only slight
up-regulation of VCAM-1 in co-cultures, while CXCR4 ligation was
required for most of the adhesion seen in synovial co-cultures. This
suggests that the receptors used for initial capture from flow were
only slightly increased and that activation of lymphocyte integrins
by CXCL12 from synovial fibroblasts was the critical factor for the
elevation of stable adhesion. An analogous situation occurred in
our previous studies, where synovial fibroblasts induced selectin-
dependent adhesion of neutrophils to EC [9]. There, selectin
expression was again barely detectable and stable adhesion
required activation of CXCR2 on the neutrophils.
When EC were stimulated with TNF-a+IFN-g, lymphocyte
adhesion was greatly reduced by combined blockade of domains 1
and 4 of VCAM-1. Blockade of a4-integrin on lymphocytes caused a
similar degree of inhibition of adhesion. Thus for co-culture, it is
likely that the interaction between a4b1-integrin and VCAM-1 was
the main basis of lymphocyte adhesion. Fibronectin has been
shown previously to contribute to adhesion of lymphoid cells lines
to HUVEC, but not PBL [23]. We attempted to quantify the level of
fibronectin on the surface of our cultures by immunofluorescence
labelling and flow cytometry, but did not detect a signal above that
obtained with non-specific control antibody (data not shown).
Thus, given the efficacy of the combined VCAM-1 blockade, no
other ligand for PBL integrin need be postulated here. The finding
that blockade of domain 4 of VCAM-1 was more effective than
domain 1 was unexpected based on some previous reports.
Domain 1 has been suggested to act as the main capture receptor
from flow [24, 25], but domain 4 may be important in adhesion
strengthening for activated lymphocytes [26]. The data presented
here mainly represent firmly adherent lymphocytes that have
remained attached for minutes, and so our data suggest that
domain 4 may be important for maintaining adhesion. E-selectin
has also been shown to make a contribution to adhesion of PBL to
TNF-a-treated HUVEC [27] and there was evidence of a minor
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Figure 6. Effect of co-culture on the gene transcriptional profiles of EC. EC were cultured alone or with human RA dermal or synovial fibroblasts
(HDF or HSF respectively) for 24 h in the absence of exogenous cytokines. Endothelial mRNA was isolated and analysed using microarray
technology on an 850 human gene array. Data was normalised (sample/reference) and then analysed by TIGR Multiple Experiment Viewer allowing
statistical analysis of microarrays (SAM) and hierarchical cluster analysis (HCA). The SAM false-positive level was set at 0%. (A) List of 18 genes
identified by SAM to vary significantly between the three culture-conditions. (B) HCA based on the 18 genes identified. The colour scale from green
to red for each gene represents the natural logarithm of the gene expression, relative to the value for the reference sample tested with it. The
different culture conditions showed distinct segmentations, as indicated by the coloured tree (blue-brown-yellow) across the top, associated with
them. Comparisons between the different culture conditions were done on three occasions, each using different primary EC isolates and different
arrays. In each array, the individual genes were tested in triplicate.
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contribution to adhesion here. Combination of antibodies against
E-selectin and domain 1 of VCAM-1 had an effect greater than
either antibody alone, suggesting both assisted in capture.
In the cytokine model, activation through CXCR3 was impor-
tant to stabilise adhesion, and EC showed strong mRNA expression
of three potential ligands for CXCR3 (CXCL9, 10 and 11). These
results are consistent with previous reports demonstrating that
CXCR3 ligands promote lymphocyte adhesion to TNF-a+IFN-g-
stimulated HUVEC [13]. Cultured synovial fibroblasts have been
shown to secrete CXCL9, CXCL10 and CXCL11 following stimula-
tion with IFN-g alone [28] or in combination with TNF-a
in vitro [29] and this might contribute to the augmentation of
adhesion in synovial co-cultures. However, down-regulation of
adhesion by co-culture with dermal fibroblasts was not associated
with reduction in the expression of these chemokines. Although
surface expression of VCAM-1 or E-selectin showed a tendency to
be reduced, this was evident in the co-cultures with synovial
fibroblasts as well. Thus while inhibition of the response to cyto-
kines in the dermal co-cultures might arise from changes in
secretion or presentation of chemokines, no firm conclusion can be
made.
Soluble mediators, in particular IL-6, played important
roles in the modulatory effects of fibroblasts. Rheumatoid
synovial fibroblasts are known to secrete a range of pro-inflam-
matory cytokines, including IL-6 [30]. Here, RA synovial
co-cultures consistently secreted higher concentrations of
IL-6 than dermal co-cultures in the absence of cytokines.
Neutralisation of IL-6 significantly inhibited lymphocyte
adhesion to EC cultured with synovial fibroblasts, as was the case
in earlier studies of neutrophils adhesion to similar co-cultures
[9]. However, when we added exogenous IL-6 to EC alone, this
did not induce an increase in lymphocyte adhesion. This is
consistent with work by Modur et al. [19], who found
that addition of soluble IL-6Ra in addition to IL-6 was
required to induce adhesion of neutrophils to EC. Previously, we
did not detect sIL-6R in co-culture supernatants [9]. In fact,
although the co-receptor Gp130 is widely expressed among
different cells, IL-6Ra is believed to be restricted in expression to
mononuclear leukocytes, fibroblasts and hepatocytes [31, 32].
Nevertheless, we examined IL-6Ra mRNA expression by qPCR
and found detectable levels, albeit much lower than those for
Gp130. Neither was modified by co-culture with synovial or
dermal fibroblasts. This led us to evaluate the surface expression
of IL-6Ra protein on EC by flow cytometry, where very low levels
were detected in two cultures but labelling was not above back-
ground in two others. Again, this was the same for mono-cultures
or co-cultures. The foregoing indicates that it is unlikely that the
IL-6 acting alone directly induced increased adhesion to EC in the
synovial co-cultures. IL-6 may have induced the synovial fibro-
blasts to increase the production of CXCL12 and/or other agents
promoting lymphocyte recruitment. However, another possibility
is that EC in the modified phenotype induced by synovial
co-culture were more responsive to IL-6 than simple mono-
cultures even though there was no evident change in the
expression of receptors (see below).
In contrast, IL-6 took on an inhibitory role in conjunction with
TGF-b, in the reduced response to cytokines induced by co-culture
of EC with dermal fibroblasts. Interestingly, we found that addition
of exogenous IL-6 greatly reduced the response of endothelial
mono-cultures to TNF-a+IFN-g. Such an inhibitory effect of IL-6 has
not been reported in EC previously to our knowledge and suggests
that the low levels of IL-6Ra, which we detected, could modify
cellular responses at least. TGF-b has been reported to suppress the
secretion of chemokines, including CXCL10, from HUVEC stimu-
lated with TNF-a+IFN-g [33]. In addition, pre-incubating human
dermal microvascular EC with TGF-b inhibited their response to
TNF-a or IL-1, and abrogated mononuclear leukocyte adhesion
[34]. In vivo, intra-tracheal injection of IL-6 with TGF-b inhibited
neutrophil extravasation into LPS-induced lung inflammation [35],
indicating that the combination can act as an inhibitor of acute
inflammation. Here, IL-6 may have modulated responses of EC to
cytokines and may also have induced dermal fibroblasts to generate
inhibitory accessory signals, including TGF-b, which reduced the
ability of EC to bind lymphocytes (e.g. by altering chemokine traf-
ficking and/or presentation as noted above). Synovial fibroblasts
released at least as much IL-6 as dermal fibroblasts, but the endo-
thelial response to TNF-a+IFN-g was not decreased in their
presence. Thus it appears either that the co-cultured EC were in an
altered phenotype that had a different response to IL-6 (as sugges-
ted above) or that secondary inhibitory agents were not released by
the synovial cells. In any case, the results indicate that a single agent
such as IL-6 can have quite different effects on an inflammatory
response depending on the local environment and presence of other
growth factors or cytokines.
Because the effects of IL-6 were disparate in the different types
of co-culture, and changes in leukocyte recruitment
were not simply attributable to changes in the expression of
adhesion molecules or chemokines by the EC, we wondered
whether the EC took on distinctive phenotypes when
cultured with synovial or dermal fibroblasts. To investigate this we
carried out gene microarray analysis for endothelial
mono-cultures and co-cultures. The analysis indicated that
although the differently cultured EC were distinguishable
by their gene expression profiles, the synovial fibroblasts
modulated a much greater number of genes than the dermal
fibroblasts, and they induced a genomic state that was much more
distinct from the EC cultured alone. This suggests that
the fibroblasts from inflamed tissue not only provided CXCL12 and
IL-6 but induced a phenotype in the EC, which was responsive to
IL-6 and adhesive to lymphocytes. On the other hand, dermal
fibroblasts left EC in a state that was not intrinsically responsive to
IL-6. Instead, we hypothesise that the dermal fibroblasts provided
IL-6, which moderated the response to cytokine treatment (an
effect reproduced in mono-cultures), rather than establishing a
new, non-responsive phenotype in advance.
In conclusion, these studies reveal that stromal cells can
modulate the inflammatory response mediated by EC and that
this modulation may itself depend on the state of the stromal cells
in question (e.g. their own exposure to a chronically-inflamed
environment). Not only fibroblasts but hepatocytes and SMC can
Eur. J. Immunol. 2009. 39: 113–125 Cellular immune response 121
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
also modulate the ability of overlying EC to recruit leukocytes
[7–9]. The effects may be directly stimulatory, or modulatory
of responses to other agonists. It appears that fibroblasts from
non-inflamed stroma can regulate the cytokine-sensitivity of
vascular endothelium, while fibroblasts associated with chronic
inflammation bypass this and develop a directly inflammatory
phenotype. In the context of RA, the effects of synovial fibroblasts
in co-culture are consistent with reports that CXCL12 is expressed
highly in the synovium of the rheumatoid joint and may promote
T-cell recruitment [36–38]. IL-6 has been implicated as a
modulator of RA in humans [39] and in animal models [40],
while in rats, inhibition of a4-integrin reduced the accumulation
of T cells into arthritic joints [41]. Thus the model described here
appears relevant to the pathology of RA in particular. More
generally, co-cultures of appropriate primary cells, with or
without added cytokines, offer a means to study physiological
processes regulating inflammation in human tissue. The results in
such systems may be complex as illustrated by the effects of IL-6
here, which depended on the local milieu and other released
factors. It is thus difficult to predict a priori which soluble
mediators should be added, e.g. to model inflammation using
endothelial mono-cultures, and further studies are needed to
fully define the regulatory or stimulatory repertoires of stromal
cells.
Materials and methods
Isolation of human PBL, fibroblasts and EC
Venous blood from healthy individuals was collected in EDTA
tubes (Sarstedt, Leicester, UK) and PBL were isolated using
histopaque 1077 followed by panning on culture plastic to
remove contaminating monocytes [42]. PBL were washed,
counted, and adjusted to a final concentration of 2 106/mL in
PBS containing Ca2+ and Mg2+ (Gibco Invitrogen Compounds,
Paisley, Scotland), 0.15% BSA and 5mM glucose (Sigma, Poole,
UK) (PBSAG).
Tissue samples from synovium and overlying skin were
obtained from the same patients with RA or with OA, and from
the synovium of a patient undergoing surgery for mechanical
injury (trauma), and fibroblasts were isolated as described
previously [43]. Cells were cultured in RPMI 1640 (Gibco)
supplemented with 10% heat inactivated FCS, MEM-non-essen-
tial amino acids, 1mM sodium pyruvate, 2mM L-glutamine,
100U/mL penicillin and 100mg/mL streptomycin (all from
Sigma) and used between passages 5 and 9.
HUVEC were isolated from umbilical cords as described
previously [44] and cultured in M199 supplemented with 20%
FCS, 10 ng/mL epithelial growth factor, 35mg/mL gentamycin,
1mg/mL hydrocortisone (all from Sigma) and 2.5 mg/mL
amphotericin B (Gibco). HUVEC were used because they were the
only primary human cells available in sufficient quantities at
early passage, for the large number of studies described here.
This was especially the case as we used first passage cells without
expansion, which might change responsiveness. In addition, we
and others have characterised the ability of HUVEC to bind
leukocytes and to respond to cytokines in great detail. Although
studies with microvascular EC would be interesting, HUVEC may
be considered as a widely used ‘generic’ EC capable of responding
to a wide range of stimuli. All human tissues were obtained with
informed consent and with approval from the local research
ethics committee.
Culture of EC alone or with fibroblasts on filter inserts
Fibroblasts and EC cultures were dissociated using trypsin/EDTA
(Sigma) and co-cultured on the opposite sides of 6-well, low-
density, 0.4mm pore Transwell filter inserts (BD Pharmingen,
Cowley, UK). Fibroblasts (7 105) were seeded onto inverted
filters and cultured for 24 h. HUVEC were then seeded on the
inner surface of inserts at a concentration that yielded confluent
monolayers within 24 h. For comparison, parallel cultures of
HUVEC alone were seeded inside inserts. The cells were cultured
in fibroblast medium for 48 h. When desired, 100U/mL of TNF
(Sigma) was added, alone or with 10 ng/mL of IFN-g (Peprotech,
London, UK), for the last 24 h. The cytokine concentrations and
combination were based on published studies in which IFN-g
potentiated T-cell recruitment induced by TNF-a [13, 15], our
own titrations of TNF-a in adhesion studies (e.g. [14]) and
preliminary studies, which verified that combination of TNF-a
and IFN-g was more effective for inducing PBL adhesion
then either alone. In some experiments, EC were cultured alone
for 24 h and then treated with 1 or 10 ng/mL of IL-6
(Immunotools, Friesoythe, Germany) for 24h prior to cytokine-
stimulation as above, where the IL-6 was present during the
cytokine-stimulation.
In studies to investigate the requirement for direct contact
between co-cultured cells, fibroblasts were seeded onto the
bottom of a 6-well plate for 24 h, after which HUVEC were seeded
inside the filters. The cells were then cultured in the same plate
for 24h prior to cytokine-stimulation as above.
Incorporation of filters into a parallel plate flow
chamber
Filters were incorporated into a parallel plate flow chamber and
connected to a perfusion system mounted on the stage of a phase-
contrast videomicroscope held at 371C, as described previously
[45]. PBL were perfused over the HUVEC for 4min, followed by
washout with cell-free PBSAG, all at a wall shear stress of 0.1 Pa.
After 2min of washout, video recordings lasting 20 s were
made of a series of fields of known area along the central axis of
the flow chamber. In each field, lymphocytes bound to the EC
were counted, and each was classified as either (i) rolling
adherent (spherical cells moving over the surface much slower
than free-flowing cells); (ii) stationary or firmly adherent
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(typically with distorted shape and actually migrating slowly on
the surface); or (iii) transmigrated under the endothelial
monolayer (phase dark and spread). In some cases, video
recordings were also made after 10min washout, and lymphocyte
behaviour re-evaluated. The total number of adherent lympho-
cytes (i.e. all three behaviours) was averaged per field and
expressed/mm2/106 cells perfused [46].
Antibody treatments
In some experiments, HUVEC were treated for 20min with the
following: ENA2 (anti-E-selectin F(ab) fragment, 1mg/mL; BD);
4B2 (anti-VCAM-1, recognising immunoglobulin domain 1,
10 mg/mL; R&D Systems, Abingdon, UK) or GH12 (anti-VCAM-
1, recognising domain 4, 10 mg/mL; kind gift from Dr. Roy Lobb)
alone or in combination. It may be noted that VCAM-1 has two
potential sites for ligation of a4b1-integrin, and both may need to
be blocked to ablate lymphocyte interaction with EC depending
on the stimulatory regime [24, 47]. Alternatively, neutralising
antibodies against IL-6 (clone 6708, 5 mg/mL; R&D) or TGF-b
(clone 1825, 5mg/mL; R&D) were added when co-culture was
established. In other experiments, lymphocytes were treated for
15min with 10 mg/mL of the following: 1C6 (anti-CXCR3; R D);
Max68P (anti-a4-integrin) or R6.5E (anti-b2-integrin) (both gifts
from Dr. Tony Shock, Cell Tech, Slough, UK). The above are IgG1
antibodies previously shown to block functions [7, 9, 15, 24,
47–49]. Alternatively, lymphocytes were treated for 15min with
1mg/mL of the CXCR4 inhibitor, AMD3100 (AnorMED, British
Columbia, Canada).
Flow cytometry of endothelial surface receptors
EC on filters were incubated with non-conjugated antibodies
against E-selectin (1.2B6) or VCAM-1 (1.4C3; both Dako, Ely,
UK) or with PE-conjugated antibody against IL-6Ra/CD126
(M91; Immunotools, UK) for 30min at 41C. Mouse IgG1
or PE-conjugated mouse IgG1 (both Dako) were used as the
negative controls. For non-conjugated primary antibodies,
samples were washed for 5min with ice-cold PBS containing
4% BSA prior to incubation with goat anti-mouse FITC-
conjugated secondary antibody (Dako) for 30min at 41C. All
samples were washed and incubated with enzyme-free cell
dissociation buffer (Sigma) for 30min. Cells were retrieved,
washed and analysed using a Coulter XL flow cytometer. Data
were expressed as MFI.
mRNA quantification by PCR
Trypsin/EDTA was used to detach HUVEC from the inside of
filters, and mRNA was isolated from the cells using the RNeasy
Mini Kit (Qiagen, Crawley, UK). mRNA levels of CXCL9, CXCL10,
and CXCL11 chemokine were analysed by RT PCR. Primers were
synthesised by Alta Biosciences (University of Birmingham, UK)
as described previously [15]. Amplified products were run on
1.25% agarose gel containing ethidium bromide, analysed by
densitometry and data expressed as percentage of b-actin band
density.
E-selectin, VCAM-1, ICAM-1, CXCL12, CD126, CD130, b-actin
and 18 S mRNA were analysed by qPCR using Quanti-TectTM
probe RT-PCR kit according to manufacturer’s instructions
(Qiagen). ICAM-1, VCAM-1, E-selectin and CD126 FAM-labelled
primers, and b-actin and 18 S VIC-labelled primers were bought
as Assay on Demand kits from Applied Biosystems (Warrington,
UK). CD130 FAM-labelled primers were from Eurogenetec
(Southampton, UK). CXCL12 (SDF-1) FAM labelled forward
(50-GCC-CGT-CAG-CCT-GAG-CTA), reverse (30 GAC-GTT-GGC-
TCT-GGC-AAC-A) and probe sequences (AGA-TGC-CCA-TGC-
CGA-TTC-TTC-GAA-A) were synthesised by Alta Biosciences.
Samples were amplified using the 7900HT Real-Time PCR
machine and analysed using the software package SDS 2.2
(Applied Biosystems). Data were expressed as REU relative to
b-actin (for E-selectin, VCAM-1, ICAM-1 and CXCL12) or 18S
(for CD126 and CD130).
mRNA analysis by custom microarray
Custom DNA microarrays analysing 850 immune-response genes
(associated with adhesion and chemokine receptors, cytokines,
apoptosis, cell cycle and intracellular signalling pathways) were
synthesized as described previously [50]. Total mRNA was extracted
from detached HUVEC using an RNAqueous kit according to
manufacturer’s instructions (Ambion, Huntington, UK). Extracted
RNA was reverse transcribed and cDNA was amplified using the
SMART cDNA synthesis kit following the manufacturer’s protocol
(BD Biosciences). The cDNA was purified using QIAquick PCR
purification kit following manufacturer’s instructions (Qiagen),
using 30mL of water for the final elution, and stored at 201C.
In-house reference sample was constructed by mixing cDNA from
human buffy coat, fibroblasts, EBV-infected cells and peripheral
blood mononuclear cells. An aliquot of 500ng of cDNA from sample
and reference was labelled by direct incorporation of dCTP,
conjugated with Cy3 and Cy5, respectively. Microarrays were
hybridized overnight at 421C (Corning, USA), washed and scanned
with GenePix 4000 microarray scanner (Axon Instruments, CA,
USA). Each gene was analysed in triplicate in each experiment. Data
were normalised (sample/reference) using the Gene Expression
Pattern Analysis Suite v3.1 software package, and then exported to
TIGR Multiple Experiment Viewer (http://www.tigr.org/software),
allowing SAM and HCA. In analyses reported here, the SAM false-
positive level was set at 0%.
Statistical analysis
Variation between multiple treatments was evaluated using ANOVA,
followed by Dunnett’s test (for comparison to control) or Bonferroni
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multiple comparison post-test as appropriate. Differences between
individual treatments were evaluated by paired t-test. po0.05 were
considered statistically significant.
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